Page last updated: 2024-08-21

hydrazine and Vomiting

hydrazine has been researched along with Vomiting in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-199020 (80.00)18.7374
1990's0 (0.00)18.2507
2000's3 (12.00)29.6817
2010's0 (0.00)24.3611
2020's2 (8.00)2.80

Authors

AuthorsStudies
Ahnert, JR; Albittar, AA; Dalal, S; Dev, R; Fu, S; Hui, D; Karp, DD; Liu, S; Meric-Bernstam, F; Naing, A; Piha-Paul, SA; Rubin, L; Tsimberidou, AM; Yap, TA; Zarifa, A; Zhong, LL1
Carter, BW; Colen, R; Fu, S; Gong, J; Hong, DS; Janku, F; Karp, DD; McQuinn, L; Meric-Bernstam, F; Milton, DR; Naing, A; Piha-Paul, SA; Shah, J; Stephen, BA; Sulovic, S; Thein, KZ; Tsimberidou, A; Yap, TA1
Chun, HO; Jung, SH; Kim, E; Kim, JH; Lee, JM; Rhee, CK; Suh, BC; Xiang, MX1
BOLLAG, W; D ALESSANDRI, A; KEEL, HJ; MARTZ, G1
Han, J; Kim, B; Kim, JC; Shin, HC1
Andreeff, M; Beran, M; Cahill, A; Clairmont, C; Cortes, J; Faderl, S; Ferrajoli, A; Garcia-Manero, G; Giles, F; Jeha, S; Kantarjian, H; Koller, C; Sznol, M; Thomas, D; Verstovsek, S1
Birket-Smith, E; Dupont, E; Hansen, E; Hyyppä, M; Marttila, R; Mikkelsen, B; Pakkenberg, H; Presthus, J; Rinne, UK1
Gilland, O1
Diamond, SG; Markham, CH; Treciokas, LJ1
Baker, AB; Lee, MC; Loewenson, RB; Martin, WE; Resch, JA; Tolosa, ES1
Marsden, CD; Parkes, JD; Rees, JE1
Birkmayer, W1
Glasgow, GL; Henley, JW; Willoughby, EW1
Förster, W; Gräbner, S1
Chandra, O; Dhawan, KN; Gupta, GP; Saxena, RC1
Dupont, E; Hansen, E; Holm, P; Melsens, S; Parkenberg, H1
Rinne, UK1
Schönfelder, H; Wälzholz, U1
Diamond, SG; Markham, C; Treciokas, LJ1
Benkert, O; Matussek, N; Otten, H; Pohlmeier, H; Schneider, K1
Bateman, JR; Irwin, LE; Jacobs, EM; Pugh, RP; Solomon, J; Steinfeld, JL; Stevens, AR; Stolinsky, DC; Wood, DA1
Calne, DB; Gawler, J; Hilson, A; Pallis, CA; Petrie, A; Rao, S; Reid, JL; Thomas, PK; Vakil, SD1
Barbeau, A; Gillo-Joffroy, L; Mars, H1
Lotti, VJ; Porter, CC1
Martin, H; Schubert, JC1

Reviews

1 review(s) available for hydrazine and Vomiting

ArticleYear
Recent advances in the treatment of Parkinsonism with drugs.
    Acta neurologica Scandinavica. Supplementum, 1972, Volume: 51

    Topics: Amantadine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Arrhythmias, Cardiac; Blood-Brain Barrier; Brain; Central Nervous System; Dihydroxyphenylalanine; Dopamine; Drug Interactions; Drug Tolerance; Humans; Hydrazines; Mental Disorders; Movement Disorders; Nausea; Parasympatholytics; Parkinson Disease; Rats; Time Factors; Vomiting

1972

Trials

13 trial(s) available for hydrazine and Vomiting

ArticleYear
Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study.
    Investigational new drugs, 2022, Volume: 40, Issue:1

    Topics: Adult; Aged; Anorexia; Antiemetics; Female; Humans; Hydrazines; Male; Middle Aged; Nausea; Neoplasms; Olanzapine; Triazoles; Vomiting; Young Adult

2022
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study.
    Investigational new drugs, 2022, Volume: 40, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Hydrazines; Lung Neoplasms; Nausea; Neoplasms; Ovarian Neoplasms; Paclitaxel; Thrombocytopenia; Triazoles; Vomiting

2022
A Phase I and pharmacokinetic study of VNP40101M, a novel sulfonylhydrazine alkylating agent, in patients with refractory leukemia.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, May-01, Volume: 10, Issue:9

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Area Under Curve; Humans; Hydrazines; Leukemia, Myeloid; Metabolic Clearance Rate; Middle Aged; Myelodysplastic Syndromes; Nausea; Sulfonamides; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting

2004
Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.
    Journal of neurology, 1975, Dec-02, Volume: 211, Issue:1

    Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Vomiting

1975
[Levodopa and decarboxylase inhibitors in Parkinson's disease].
    Lakartidningen, 1977, Jan-05, Volume: 74, Issue:1-2

    Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting

1977
A double-blind comparison of levodopa, Madopa, and Sinemet in Parkinson disease.
    Annals of neurology, 1978, Volume: 3, Issue:3

    Topics: Adult; Benserazide; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting

1978
The effects of combining carbidopa with levodopa for Parkinson's disease.
    Geriatrics, 1975, Volume: 30, Issue:12

    Topics: Carbidopa; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrazines; Hypotension, Orthostatic; Levodopa; Male; Nausea; Parkinson Disease; Vomiting

1975
A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone.
    Lancet (London, England), 1973, Dec-29, Volume: 2, Issue:7844

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Blood Urea Nitrogen; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Humans; Hydrazines; Nausea; Parkinson Disease; Placebos; Time Factors; Vomiting

1973
[10 years of L-DOPA therapy of Parkinson's syndrome].
    Wiener klinische Wochenschrift, 1971, Apr-02, Volume: 83, Issue:13

    Topics: Administration, Oral; Amphetamine; Animals; Brain Chemistry; Catecholamines; Clinical Trials as Topic; Cognition Disorders; Constipation; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Feeding and Eating Disorders; Hallucinations; Humans; Huntington Disease; Hydrazines; Hypertension; Infusions, Parenteral; Injections, Intravenous; Monoamine Oxidase Inhibitors; Movement Disorders; Nausea; Norepinephrine; Parkinson Disease; Serotonin; Stimulation, Chemical; Time Factors; Tremor; Vomiting

1971
L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease.
    Australian and New Zealand journal of medicine, 1974, Volume: 4, Issue:4

    Topics: Aged; Blood Pressure; Carbidopa; Clinical Trials as Topic; Depression, Chemical; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Placebos; Posture; Vomiting

1974
[Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions].
    Arzneimittel-Forschung, 1970, Volume: 20, Issue:7

    Topics: Adolescent; Adult; Aged; Blood Pressure; Carboxy-Lyases; Clinical Trials as Topic; Depression; Dihydroxyphenylalanine; Female; Galvanic Skin Response; Heart Rate; Humans; Hydrazines; Male; Middle Aged; Nausea; Placebos; Respiration; Vomiting

1970
Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.
    British medical journal, 1971, Sep-25, Volume: 3, Issue:5777

    Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Hydrazines; Male; Methyldopa; Middle Aged; Nausea; Parkinson Disease; Vomiting

1971
[Cytostatic treatment of lymphogranulomatosis. Experiences with ibenzmethyzine, cyclophosphamide and vinblastine sulfate].
    Munchener medizinische Wochenschrift (1950), 1968, Jan-12, Volume: 110, Issue:2

    Topics: Alopecia; Ambulatory Care; Antineoplastic Agents; Cyclophosphamide; Hodgkin Disease; Humans; Hydrazines; Injections, Intravenous; Leukopenia; Nausea; Sulfates; Thrombocytopenia; Thrombophlebitis; Vinblastine; Vomiting

1968

Other Studies

11 other study(ies) available for hydrazine and Vomiting

ArticleYear
Improvement of therapeutic index of phosphodiesterase type IV inhibitors as anti-Asthmatics.
    Bioorganic & medicinal chemistry letters, 2003, Jul-21, Volume: 13, Issue:14

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Asthmatic Agents; Binding Sites; Brain; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Cyclic Nucleotide Phosphodiesterases, Type 4; Ferrets; Guinea Pigs; Hydrazines; In Vitro Techniques; Inflammation; Models, Molecular; Muscle Relaxation; Phosphodiesterase Inhibitors; Rolipram; Structure-Activity Relationship; Trachea; Vomiting

2003
PRELIMINARY CLINICAL RESULTS WITH A NEW ANTITUMOR AGENT RO 4-6467 (NSC-77213).
    Cancer chemotherapy reports, 1963, Volume: 33

    Topics: Antineoplastic Agents; Bone Marrow Diseases; Eosinophilia; Geriatrics; Hemolysis; Hodgkin Disease; Hydrazines; Leukemia; Leukemia, Lymphoid; Lymphocytosis; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Nausea; Neoplasms; Radiography, Thoracic; Toxicology; Vomiting

1963
Subacute toxicity and toxicokinetics of CJ-10882, a type IV phosphodiesterase inhibitor, after 4-week repeated oral administration in dogs.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2004, Volume: 42, Issue:3

    Topics: Administration, Oral; Animals; Area Under Curve; Atrophy; Body Weight; Cyclopentanes; Dogs; Dose-Response Relationship, Drug; Eating; Female; Hydrazines; Male; Phosphodiesterase Inhibitors; Salivation; Thymus Gland; Toxicity Tests; Vomiting

2004
[The effect of dopamine and MAO inhibitors on centrally stimulated vomiting].
    Acta biologica et medica Germanica, 1966, Volume: 16, Issue:6

    Topics: Animals; Apomorphine; Dogs; Dopamine; Drug Synergism; Hydrazines; Indoles; Iproniazid; Monoamine Oxidase Inhibitors; Nialamide; Phenelzine; Picolines; Tranylcypromine; Vomiting

1966
Assessment of anti-reserpine and anti-apomorphine activities of some psychic energizers in pigeons.
    Psychopharmacologia, 1969, Volume: 15, Issue:4

    Topics: Amitriptyline; Animals; Antidepressive Agents; Apomorphine; Columbidae; Deanol; Desipramine; Female; Hydrazines; Imipramine; Male; Opipramol; Orphenadrine; Reserpine; Vomiting

1969
Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone).
    Acta neurologica Scandinavica. Supplementum, 1972, Volume: 51

    Topics: Administration, Oral; Aromatic Amino Acid Decarboxylase Inhibitors; Capsules; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hydrazines; Movement Disorders; Nausea; Parkinson Disease; Retrospective Studies; Time Factors; Vomiting

1972
[Advances in L-DOPA therapy for parkinsonism through combination with a decarboxylase inhibitor. Results of a long-term study].
    Der Nervenarzt, 1972, Volume: 43, Issue:10

    Topics: Adult; Aged; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Hydrazines; Long-Term Care; Male; Middle Aged; Nausea; Parkinson Disease; Time Factors; Vomiting

1972
Carbidopa in Parkinson disease and in nausea and vomiting of levodopa.
    Archives of neurology, 1974, Volume: 31, Issue:2

    Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Humans; Hydrazines; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting

1974
Clinical experience with procarbazine in Hodgkin's disease, reticulum cell sarcoma, and lymphosarcoma.
    Cancer, 1970, Volume: 26, Issue:5

    Topics: Alopecia; Ataxia; Carbazoles; Hodgkin Disease; Humans; Hydrazines; Leukopenia; Lymphoma, Non-Hodgkin; Lymphopenia; Mental Disorders; Nausea; Stomatitis; Vomiting

1970
Adverse clinical side effects of levodopa therapy.
    Contemporary neurology series, 1971, Volume: 8

    Topics: Antiparkinson Agents; Arrhythmias, Cardiac; Benserazide; Carboxy-Lyases; Dihydroxyphenylalanine; Edema; Endocrine System Diseases; Feeding and Eating Disorders; Hematopoiesis; Humans; Hydrazines; Libido; Movement Disorders; Myocardial Infarction; Nausea; Neurologic Manifestations; Respiration; Time Factors; Uric Acid; Urination Disorders; Vomiting

1971
Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.
    The Journal of pharmacology and experimental therapeutics, 1970, Volume: 172, Issue:2

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Blepharoptosis; Brain; Brain Chemistry; Columbidae; Dihydroxyphenylalanine; Dogs; Dopamine; Drug Antagonism; Drug Synergism; Female; Hydrazines; Hypothermia; Male; Methylcellulose; Mice; Motor Activity; Propionates; Rats; Reserpine; Stereoisomerism; Vomiting

1970